Prevalence and associated factors of diabetic retinopathy. The Beijing Eye Study 2006

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 246, Issue 11, 2008, Pages 1519-1526

  Xie, Xi Wei ^a   Xu, Liang ^a   Wang, Ya Xing ^a   Jonas, Jost B ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Diabetes mellitus; Diabetic retinopathy; Low vision; Visual field loss; Visual impairment

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; EYE EXAMINATION; FEMALE; HUMAN; HYPERMETROPIA; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MICROANEURYSM; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REFRACTION ERROR; RETINA MACULA EDEMA; RISK FACTOR; RURAL POPULATION; SELF REPORT; TONOMETRY; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CHINA; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETIC RETINOPATHY; FASTING; FEMALE; HUMANS; HYPEROPIA; HYPERTENSION; INSULIN; LIPOPROTEINS, HDL; MACULAR EDEMA; MALE; MIDDLE AGED; PREVALENCE; RURAL POPULATION; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 54049124450     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-008-0884-6     Document Type: Article

References (38)

1. Tielsch JM, Sommer A, Witt K, Katz J, Royall RM (1990) Blindness and visual impairment in an American urban population: The Baltimore Eye Survey. Arch Ophthalmol 108:286-290
2. Attebo K, Mitchell P, Smith W (1996) Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. Ophthalmology 103:357-364
3. Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT (1998) Age-specific prevalence and causes of blindness and visual impairment in an older population: The Rotterdam Study. Arch Ophthalmol 116:653-658
4. Munoz B, West SK, Rubin GS, Schein OD, Quigley HA, Bressler SB et al (2000) Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study. Arch Ophthalmol 118:819-825
5. Hyman L, Wu SY, Connell AM, Schachat A, Nemesure B, Hennis A et al (2001) Prevalence and causes of visual impairment in The Barbados Eye Study. Ophthalmology 108:1751-1756, doi: 10.1016/S0161-6420(01)00590-5
6. Ramrattan RS, Wolfs RC, Panda-Jonas S, Jonas JB, Bakker D, Pols HA et al (2001) Prevalence and causes of visual field loss in the elderly and associations with impairment in daily functioning: The Rotterdam Study. Arch Ophthalmol 119:1788-1794
7. Congdon N, O'Colmain B, Klaver CC, Klein R, Munoz B, Friedman DS, Eye Diseases Prevalence Research Group et al (2004) Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122:477-485
8. Varma R, Ying-Lai M, Klein R, Azen SP, Los Angeles Latino Eye Study Group (2004) Prevalence and risk indicators of visual impairment and blindness in Latinos: The Los Angeles Latino Eye Study. Ophthalmology 111:1132-1140, doi: 10.1016/j.ophtha.2004.02.002
9. No authors listed (2000) Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med 342:381-389, doi: 10.1056/NEJM200002103420603
10. Writing Team for the Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group (2002) Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287:2563-2569, doi: 10.1001/ jama.287.19.2563
11. Stevens RJ, Stratton IM, Holman RR, UK Prospective Diabetes Study (UKPDS58) (2002) UKPDS58 - modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetes. J Diabetes Complications 16:371-376, doi: 10.1016/S1056-8727(02)00161-7
12. Matthews DR, Stratton IM, Aldington SJ, Holman RR, Kohner EM, UK Prospective Diabetes Study Group (2004) Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Arch Ophthalmol 122:1631-1640, doi: 10.1001/archopht.122.11.1631
13. West SK, Munoz B, Klein R, Broman AT, Sanchez R, Rodriguez J et al (2002) Risk factors for Type II diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. Am J Ophthalmol 134:390-398, doi: 10.1016/S0002-9394(02)01595-7
14. Lyons TJ, Jenkins AJ, Zheng D, Lackland DT, McGee D, Garvey WT et al (2004) Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/ EDIC cohort. Invest Ophthalmol Vis Sci 45:910-918, doi: 10.1167/ iovs.02-0648
15. Varma R, Macias GL, Torres M, Klein R, Pena FY, Azen SP, The Los Angeles Latino Eye Study Group (2007) Biologic risk factors associated with diabetic retinopathy: The Los Angeles Latino Eye Study. Ophthalmology 114:1332-1340, doi: 10.1016/j.ophtha.2006.10.023
16. Pradeepa R, Anitha B, Mohan V, Ganesan A, Rema M (2008) Risk factors for diabetic retinopathy in a South Indian Type 2 diabetic population-the Chennai Urban Rural Epidemiology Study (CURES) Eye Study 4. Diabet Med 2008(Mar):13. Epub ahead of print
17. Li S, Xu J, He M, Wu K, Munoz SR, Ellwein LB (1999) A survey of blindness and cataract surgery in Doumen County, China. Ophthalmology 106:1602-1608, doi: 10.1016/S0161-6420(99)90459-1
18. Liu JH, Cheng CY, Chen SJ, Lee FL (2001) Visual impairment in a Taiwanese population: Prevalence, causes, and socioeconomic factors. Ophthalmic Epidemiol 8:339-350
19. Michon JJ, Lau J, Chan WS, Ellwein LB (2002) Prevalence of visual impairment, blindness, and cataract surgery in the Hong Kong elderly. Br J Ophthalmol 86:133-139, doi: 10.1136/bjo.86.2.133
20. Hsu WM, Cheng CY, Liu JH, Tsai SY, Chou P (2004) Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: The Shihpai Eye Study. Ophthalmology 111:62-69, doi: 10.1016/ j.ophtha.2003.05.011
21. Saw SM, Foster PJ, Gazzard G, Seah S (2004) Causes of blindness, low vision, and questionnaire-assessed poor visual function in Singaporean Chinese adults: The Tanjong Pagar. Surv Ophthalmol 111:1161-1168
22. Dunzhu S, Wang FS, Courtright P, Liu L, Tenzing C, Noertjojo K et al (2003) Blindness and eye diseases in Tibet: Findings from a randomised, population based survey. Br J Ophthalmol 87:1443-1448, doi: 10.1136/ bjo.87.12.1443
23. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053, doi: 10.2337/diacare.27.5.1047
24. Xu L, Wang Y, Wang S, Wang Y, Jonas JB (2007) High myopia and glaucoma susceptibility. The Beijing Eye Study. Ophthalmology 114:216-220, doi: 10.1016/j.ophtha.2006.06.050
25. Xu L, Li Y, Zheng Y, Jonas JB (2006) Associated factors for age-related maculopathy in the adult population in China. The Beijing Eye Study. Br J Ophthalmol 90:1087-1090, doi: 10.1136/bjo.2006.096123
26. Early Treatment of Diabetic Retinopathy Study Research Group (1991) Grading diabetic retinopathy from stereoscopic colour fundus photographs: An extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 98:786-806
27. Wing TY, Klein R, Islam FM, Cotch FM, Folsom AR, Klein BE et al (2006) Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol 141:539-541, doi: 10.1016/j.ajo.2005.11.038
28. Cikamantana L, Mitchell P, Rochtchina E, Foran S, Wang JJ (2007) Five-year incidence and progression of diabetic retinopathy in a defined older population: The Blue Mountains Eye Study. Eye 21:465-471
29. Leske MC, Wu SY, Hennis A, Hyman L, Nemesure B, Yang L, Barbados Eye Study Group et al (2005) Hyperglycemia, blood pressure, and the 9-year incidence of diabetic retinopathy: The Barbados Eye Studies. Ophthalmology 112:799-805, doi: 10.1016/j.ophtha.2004.11.054
30. Brown JB, Pedula KL, Summers KH (2003) Diabetic retinopathy: contemporary prevalence in a well-controlled population. Diabetes Care 26:2691-2692, doi: 10.2337/diacare.26.9.2637
31. Tapp RJ, Shaw JE, Harper CA, de Courten MP, Balkau B, McCarthy DJ, Taylor HR, Welborn TA, Zimmet PZ, AusDiab Study Group (2003) The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 26:1731-1737, doi: 10.2337/ diacare.26.6.1731
32. Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V (2005) Prevalence of diabetic retinopathy in urban India: The Chennai Urban Rural Epidemiology Study (CURES) Eye Study, I. Invest Ophthalmol Vis Sci 46:2328-2333, doi: 10.1167/iovs.05-0019
33. van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM et al (2002) Blood pressure, lipids, and obesity are associated with retinopathy: The Hoorn study. Diabetes Care 25:1320-1325, doi: 10.2337/ diacare.25.8.1320
34. Moss SE, Klein R, Klein BE (1996) Cigarette smoking and ten-year progression of diabetic retinopathy. Ophthalmology 103:1438-1442
35. Klein R, Sharrett AR, Klein BE, Moss SE, Folsom AR, Wong TY, ARIC Group et al (2002) The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes: The atherosclerosis risk in communities study. Ophthalmology 109:1225-1234, doi: 10.1016/ S0161-6420(02)01074-6
36. Leung H, Wang JJ, Rochtchina E, Wong TY, Klein R, Mitchell P (2005) Dyslipidaemia and microvascular disease in the retina. Eye 19:861-868, doi: 10.1038/sj.eye.6701668
37. van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, van Duijn CM, Stricker BH et al (2004) Cholesterol and age-related macular degeneration: Is there a link? Am J Ophthalmol 137:750-752
38. Klein R, Klein BE, Tomany SC, Cruickshanks KJ (2003) The association of cardiovascular disease with the long-term incidence of age-related maculopathy: The Beaver Dam eye study. Ophthalmology 110:636-643, doi: 10.1016/S0161-6420(02)01448-3